Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Diabetes Care. 2023 Jan 1;46(1):197-205. doi: 10.2337/dc22-1586.
To study prognosis after a first-ever myocardial infarction (MI) in type 1 diabetes, as well as how different MI- and diabetes-related factors affect the prognosis and risk of secondary cardiovascular events.
In this observational follow-up study of 4,217 individuals from the Finnish Diabetic Nephropathy (FinnDiane) Study with no prior MI or coronary revascularization, we verified 253 (6.0%) MIs from medical records or death certificates. Mortality from cardiovascular or diabetes-related cause was our main end point, whereas hospitalization due to heart failure, coronary revascularization, and recurrent MI were secondary end points, while accounting for death as a competing risk.
Of the individuals studied, 187 (73.9%) died during the median post-MI follow-up of 3.07 (interquartile range 0.02-8.45) years. Independent risk factors for cardiovascular and diabetes-related mortality were estimated glomerular filtration rate categories grade 3 (G3) (hazard ratio [HR] 3.27 [95% CI 1.76-6.08]), G4 (3.62 [1.69-7.73]), and G5 (4.03 [2.24-7.26]); prior coronary heart disease diagnosis (1.50 [1.03-2.20]); and older age at MI (1.03 [1.00-1.05]). Factors associated with lower mortality were acute revascularization (HR 0.35 [95% CI 0.18-0.72]) and subacute revascularization (0.39 [0.26-0.59]). In Fine and Gray competing risk analyses, kidney failure was associated with a higher risk of recurrent MI (subdistribution HR 3.27 [95% CI 2.01-5.34]), heart failure (3.76 [2.46-5.76]), and coronary revascularization (3.04 [1.89-4.90]).
Individuals with type 1 diabetes have a high cardiovascular and diabetes-related mortality after their first-ever MI. In particular, poor kidney function is associated with high mortality and excessive risk of secondary cardiovascular events.
研究首次心肌梗死(MI)后 1 型糖尿病的预后,以及不同的 MI 和糖尿病相关因素如何影响预后和二次心血管事件的风险。
在这项对来自芬兰糖尿病肾病(FinnDiane)研究的 4217 名无既往 MI 或冠状动脉血运重建史的个体进行的观察性随访研究中,我们从病历或死亡证明中核实了 253 例(6.0%)MI。心血管或糖尿病相关原因导致的死亡率是我们的主要终点,而心力衰竭、冠状动脉血运重建和复发性 MI 的住院治疗是次要终点,同时将死亡视为竞争风险。
在所研究的个体中,187 人(73.9%)在 MI 后中位 3.07 年(四分位距 0.02-8.45)的随访期间死亡。估计肾小球滤过率(eGFR)分级 3 级(G3)(危险比[HR]3.27[95%CI1.76-6.08])、G4(3.62[1.69-7.73])和 G5(4.03[2.24-7.26])、既往冠心病诊断(1.50[1.03-2.20])和 MI 时年龄较大(1.03[1.00-1.05])是心血管和糖尿病相关死亡的独立危险因素。较低死亡率的相关因素是急性血运重建(HR0.35[95%CI0.18-0.72])和亚急性血运重建(0.39[0.26-0.59])。在 Fine 和 Gray 竞争风险分析中,肾衰竭与复发性 MI(亚分布 HR 3.27[95%CI2.01-5.34])、心力衰竭(3.76[2.46-5.76])和冠状动脉血运重建(3.04[1.89-4.90])的风险增加相关。
1 型糖尿病患者首次 MI 后心血管和糖尿病相关死亡率较高。特别是,肾功能不佳与高死亡率和过度的二次心血管事件风险相关。